Pfizer Consumer Healthcare Australia
Whoa! How did you get here? This company profile is not meant to be publicly available. Research on this company is incomplete, and the overall rating has been disabled, but while you are here feel free to have a look at the info we do have.
OVERALL |
|
Owned |
UK |
Rating |
N/A |
Pharmaceuticals manufacturer and distributor
Company Ownership
Pfizer Consumer Healthcare Pty Ltd | AUS | website | ||||
GSK Consumer Healthcare
owns 100% of Pfizer Consumer Healthcare Pty Ltd |
UK | website | ||||
Pharmaceuticals This huge consumer healthcare joint venture between GSK and Pfizer kicked off in August 2019. GSK intends to demerge the joint venture in 2022, creating two new UK-based global companies focused on pharmaceuticals/vaccines and consumer healthcare. |
Company Assessment
PRAISE | CRITICISM | INFORMATION | ||
Pfizer Consumer Healthcare Pty Ltd | ||||
This company received a packaging performance level of 3 (Advanced) in its 2023 APCO Annual Report. Australian Packaging Covenant Organisation (APCO) is a not-for-profit organisation leading the development of a circular economy for packaging in Australia. Each year, APCO Members are required to submit an APCO Annual Report and Action Plan, which includes an overall performance level from 1 (Getting Started) to 5 (Beyond Best Practice).
Source: APCO (2023) |
Pfizer's controversial arrangement with the Pharmacy Guild of Australia to pay dispensing pharmacists for signing up consumers to support programs has been broadly criticised for various reasons. The company's smoking cessation treatment Champix (generic name varenicline) has a controversial history and is known to cause a range of side effects including nausea, insomnia, abnormal dreams, headache, constipation and even suicidal behaviour.
Source: The Conversation (2011)
A Medicines Australia Code of Conduct meeting in June 2012 ruled that Pfizer breached advertising regulations when the company released "community service announcements" in mainstream newspapers in response to a surge in patients reporting they had been told Lipitor (atorvastatin) was no longer available. The company was fined $50,000.
Source: Medicines Australia (2012)
In 2013 and 2012 the Therapeutic Goods Administration's Complaints Resolution Panel upheld complaints about ads by this company on the grounds that they breached advertising codes. The Panel requested this company withdraw the ads and not to use representations in the ads again.
Source: TGA Complaints Register (2013)
According to the democracyforsale.net website, this company donated $317,272 to Australia's major political parties between 2012 and 2018, as disclosed to the Australian Electoral Commision (AEC).
Source: Democracy For Sale (2018) |
|||
GSK Consumer Healthcare | ||||
The PalmOil Scan app, produced by the World Association of Zoos and Aquariums (WAZA), rates companies on their commitment to sourcing sustainable palm oil. Companies are scored on their use of certified sustainable palm oil (CSPO), commitment to sourcing CSPO, on-the-ground conservation action, and membership to the RSPO. Companies can earn a rating of Excellent, Good, Poor or No Commitment. This company is rated "Good" (retrieved 18 Nov 2023).
Source: WAZA (2023) |
GSK Consumer Healthcare is a joint venture between the consumer health divisions of GSK and Pfizer. Both companies have criticisms and a Shop Ethical rating of 'F'.
Source: Shop Ethical (2020) |
Company Details
Type | Wholly-owned subsidiary |
Aus Manufacturing | Yes |
Contact Details
Address | Level 15-18, 151 Clarence St, Sydney, NSW, 2000, Australia |
Phone | 02 9850 3333 |
Freecall | 1800 555 057 |
info.australia@pfizer.com | |
Website | www.pfizerconsumer.com.au |